Research Article
Application of Samarium- and Terbium-Sensitized Luminescence via a Multivariate-Based Approach for the Determination of Orbifloxacin
Table 9
Determination of ORLX in the formulation under the optimum conditions. Direct calibration and standard addition methods were performed.
| | ORLX-Sm(III) | ORLX-Tb(III) |
| Direct calibration method | Taken (ng/mL) | Found (ng/mL) | % recovery | Found (ng/mL) | % recovery | 25.00 | 24.83 | 99.31 | 25.54 | 102.16 | 50.00 | 48.75 | 97.50 | 49.15 | 98.30 | 100.0 | 96.40 | 96.40 | 100.09 | 100.09 | 200.0 | 208.57 | 104.29 | 198.20 | 99.10 | 300.0 | 298.66 | 99.55 | 304.27 | 101.42 | 400.0 | 397.78 | 99.45 | 397.75 | 99.44 | Mean ± SD | | 99.42 ± 2.70 | | 100.09 ± 1.46 | RSD | 2.72 | 1.46 | | |
| Standard addition method | Taken (ng/mL) | Added (ng/mL) | % recovery | Added (ng/mL) | % recovery | 100.0 | — | 95.64 | — | 96.67 | 100.0 | 50 | 96.26 | 50 | 102.76 | 100.0 | 100 | 100.37 | 100 | 103.99 | 100.0 | 150 | 99.24 | 150 | 98.87 | 100.0 | 200 | 102.16 | 200 | 97.22 | 100.0 | 250 | 100.15 | 250 | 101.69 | 100.0 | 300 | 98.97 | 300 | 100.88 | Mean ± SD | | 99.64 ± 2.16 | | 100.91 ± 2.79 | RSD | | 2.17 | | 2.77 |
|
|